AR104448A2 - Una composición que comprende un pestivirus atenuado de dvb - Google Patents

Una composición que comprende un pestivirus atenuado de dvb

Info

Publication number
AR104448A2
AR104448A2 ARP160101219A ARP160101219A AR104448A2 AR 104448 A2 AR104448 A2 AR 104448A2 AR P160101219 A ARP160101219 A AR P160101219A AR P160101219 A ARP160101219 A AR P160101219A AR 104448 A2 AR104448 A2 AR 104448A2
Authority
AR
Argentina
Prior art keywords
npro
deletion
coding sequence
dvb
composition
Prior art date
Application number
ARP160101219A
Other languages
English (en)
Inventor
Von Freyburg Martina
Meyer Christiane
Ege Andreas
Meyers Gregor
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR104448(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of AR104448A2 publication Critical patent/AR104448A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reivindicación 1: Una composición que comprende un pestivirus atenuado de DVB de tipo 2, cepa viral NY93, caracterizada porque comprende: a) una deleción del residuo histidina en la posición aminoacídica 349 de la glicoproteína Eʳⁿˢ, donde dicha deleción en la secuencia codificante de la glicoproteína Eʳⁿˢ conduce a la inactivación de la actividad de RNasa que reside en la glicoproteína Eʳⁿˢ; y b) otra deleción en la secuencia codificante de Nᵖʳᵒ, donde dicha deleción en la secuencia codificante de Nᵖʳᵒ conduce a una proteína Nᵖʳᵒ que está codificada solo por los aminoácidos MELF, y donde dicha mutación en la secuencia codificante para Nᵖʳᵒ conduce a la inactivación de dicha Nᵖʳᵒ; c) una solución.
ARP160101219A 2004-05-19 2016-04-28 Una composición que comprende un pestivirus atenuado de dvb AR104448A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV

Publications (1)

Publication Number Publication Date
AR104448A2 true AR104448A2 (es) 2017-07-19

Family

ID=34967522

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050102032A Pending AR049176A1 (es) 2004-05-19 2005-05-18 Vacuna que comprende un pestivirus atenuado
ARP160101219A AR104448A2 (es) 2004-05-19 2016-04-28 Una composición que comprende un pestivirus atenuado de dvb

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP050102032A Pending AR049176A1 (es) 2004-05-19 2005-05-18 Vacuna que comprende un pestivirus atenuado

Country Status (25)

Country Link
EP (1) EP1751276B9 (es)
JP (2) JP5006782B2 (es)
KR (1) KR100908798B1 (es)
CN (2) CN103352030B (es)
AR (2) AR049176A1 (es)
AT (1) ATE420949T1 (es)
AU (1) AU2005243488B2 (es)
BR (1) BRPI0510396B1 (es)
CA (1) CA2561719C (es)
CY (4) CY1109036T1 (es)
DE (2) DE102004025452A1 (es)
DK (1) DK1751276T5 (es)
ES (1) ES2321210T3 (es)
HU (2) HUS1500033I1 (es)
LU (3) LU92749I2 (es)
ME (1) ME01119B (es)
MX (1) MXPA06013298A (es)
NL (3) NL300744I2 (es)
NZ (1) NZ552088A (es)
PL (1) PL1751276T3 (es)
PT (1) PT1751276E (es)
RS (1) RS50753B9 (es)
SI (1) SI1751276T1 (es)
UY (1) UY28905A1 (es)
WO (1) WO2005111201A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
WO2008034857A1 (en) 2006-09-22 2008-03-27 Intervet International B.V. Pestivirus mutant for use in a vaccine
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8815255B2 (en) 2008-10-31 2014-08-26 Boehringer Ingelheim Vetmedica, Inc. Use of Mycoplasma bovis antigen
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
EP2618841B1 (en) * 2010-09-21 2016-10-19 Intervet International B.V. Bvdv vaccine
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
ES2757927T3 (es) * 2014-05-23 2020-04-30 Boehringer Ingelheim Vetmedica Gmbh Virus de la peste porcina clásica (VPPC) recombinante que comprende sustituciones en el epítopo TAV de la proteína E2
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) * 2023-01-11 2024-06-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) * 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
NL300743I2 (es) 2016-01-26
CN103352030B (zh) 2018-08-10
DK1751276T5 (da) 2020-07-20
HUS1500031I1 (hu) 2019-11-28
EP1751276A1 (en) 2007-02-14
KR20070012862A (ko) 2007-01-29
EP1751276B1 (en) 2009-01-14
DE102004025452A1 (de) 2006-01-19
RS50753B9 (sr) 2020-08-31
EP1751276B9 (en) 2020-05-27
JP2007537740A (ja) 2007-12-27
CA2561719A1 (en) 2005-11-24
CY2015023I2 (el) 2024-02-16
LU92749I2 (fr) 2015-11-02
CY1109036T1 (el) 2014-07-02
NL300745I1 (es) 2016-01-26
JP2012061001A (ja) 2012-03-29
BRPI0510396B1 (pt) 2020-08-18
CA2561719C (en) 2015-01-27
ES2321210T3 (es) 2009-06-03
JP5006782B2 (ja) 2012-08-22
CY2015022I1 (el) 2020-05-29
KR100908798B1 (ko) 2009-07-22
LU92747I2 (fr) 2015-11-02
UY28905A1 (es) 2005-12-30
NZ552088A (en) 2009-10-30
JP5562316B2 (ja) 2014-07-30
ME01119B (me) 2013-03-20
ES2321210T9 (es) 2020-11-04
DE602005012381D1 (de) 2009-03-05
BRPI0510396A (pt) 2007-11-13
CN1989240B (zh) 2013-07-31
PT1751276E (pt) 2009-02-24
ATE420949T1 (de) 2009-01-15
CY2015023I1 (el) 2020-05-29
AU2005243488A1 (en) 2005-11-24
NL300743I1 (es) 2016-01-26
AU2005243488B2 (en) 2011-07-07
WO2005111201A1 (en) 2005-11-24
NL300744I1 (es) 2016-01-26
CY2015021I1 (el) 2020-05-29
RS50753B (sr) 2010-08-31
SI1751276T1 (sl) 2009-06-30
CY2015021I2 (el) 2023-11-15
NL300744I2 (es) 2016-01-26
HUS1500033I1 (hu) 2015-07-28
CY2015022I2 (el) 2024-02-16
MXPA06013298A (es) 2007-05-07
PL1751276T3 (pl) 2009-06-30
NL300745I2 (es) 2016-01-26
CN103352030A (zh) 2013-10-16
LU92748I2 (fr) 2015-11-02
AR049176A1 (es) 2006-07-05
CN1989240A (zh) 2007-06-27
DK1751276T3 (da) 2009-05-18

Similar Documents

Publication Publication Date Title
AR104448A2 (es) Una composición que comprende un pestivirus atenuado de dvb
AR029851A1 (es) Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
SG10201901482XA (en) Oncolytic adenovirus encoding a b7 protein
ECSP066495A (es) Composiciones y metodos para inhibir la infección por virus de síndrome de punto blanco (wssv)
AR057213A1 (es) Acidos nucleicos que codifican secuencias tgev y prrsv para la expresion mejorada de secuencias prrsv
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
ES2531290T3 (es) Transferasas y oxidorreductasas, ácidos nucleicos que las codifican y métodos para prepararlas y usarlas
CO5700785A2 (es) Composiciones inmunogenicas novedosas para la prevencion y el tratamiento de enfermedad meningococal
AR049014A1 (es) Mimeticuerpos de glp-1 humanos , composiciones y usos
ECSP093601A (es) Proteínas derivadas del virus del síndrome de mancha blanca y sus usos
CL2008003794A1 (es) Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
AR049177A1 (es) Polipeptidos y conjugados de interferon-alfa
CO6210761A2 (es) Vectores de virus oncoliticos de viruela
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
AR074311A1 (es) Variantes de subtilisina aislada de bacillus, con actividad proteolitica
EA200870304A1 (ru) Псевдоинфекционный флавивирус и его применение
NO20052149L (no) Polynukleotidvaksine omfattende sekvens som koder for hepatitt C-virus protein.
MX2011006846A (es) Virus de fiebre porcina clasico recombinante (csfv) comprendiendo una proteina e2 modificada y metodos para generar dicho csfv.
AR050085A1 (es) Procedimiento para la generacion de plantas transgenicas con resistencia aumentada a patogenos por modificacion del contenido y/o la actividad de factores despolimerizantes de actina.
CO6260151A2 (es) Peptido de cdh3 y agente medicinal que comprende al mismo
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
UY28867A1 (es) Factor de permisividad celular para virus y usos del mismo
ATE552344T1 (de) Viren mit erhöhter lytischer kraft
BR0015197A (pt) Copolìmero vinìlico, e, composição
AR072302A1 (es) Pestivirus atenuados. composicion inmunogenica. metodo.

Legal Events

Date Code Title Description
FC Refusal